Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Why publish with us
Contact us
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Data Policies
Publication Ethics and Publication Malpractice Statement
REVIEW
Primary bronchiolar disorders: diagnosis and treatment
1
Pneumonology Department, “VenizeleioPananeio” General Hospital, Herakleio, Crete
Corresponding author
Konstantinos Pappas
Pneumonology Department, “Venizeleio-Pananeio” General Hospital, Herakleio, Crete Knossos Avenue, POB 44
Pneumonology Department, “Venizeleio-Pananeio” General Hospital, Herakleio, Crete Knossos Avenue, POB 44
Pneumon 2010;23(1):64-79
KEYWORDS
ABSTRACT
Bronchiolitis is a generic term applied to a variety of inflammatory diseases that affect the bronchioles, sparing a considerable portion of the other parenchymal structures, in which both inflammatory cells and mesenchymal tissue are present. Bronchiolitis occurs in a variety of clinical settings and may be associated with large airway disease and parenchymal disease. The symptoms and signs of bronchiolitis are nonspecific and polymorphous. The course is usually chronic, but it may be acute or subacute. The advent of high resolution computerized tomography scan (HRCT) has enabled the identification of more specific patterns that correlate with the involvement of the small airways, and it is clinically useful for confirmation of suspected bronchiolar lesions. Recently, improvement has been noted in the prognosis and clinical outcome of the disease mainly as a result of the application of macrolide treatment. Currently many clinical trials are in progress aimed at the identification of the most appropriate treatment for each specific type of bronchiolitis.
REFERENCES (95)
1.
Müller NL, Miller RR. Diseases of the bronchioles: CT and histopathologic findings. Radiology 1995;196:3–12.
2.
Franquet T, Stern EJ. Bronchiolar inflammatory diseases: highresolution CT findings with histologic correlation. Eur Radiol 1999;9:1290–303.
3.
Takahashi M, Murata K, Takazakura R, et al. Bronchiolar disease: spectrum and radiologic findings. Eur J Radiol 2000;35:15- 29.
4.
Hogg JC. Bronchiolitis in asthma and chronic obstructive pulmonary disease. Clin Chest Med 1993;14:733–40.
5.
McGuiness G, Naidich DP. CT of airways disease and bronchiectasis. Radiol Clin North Am 2002;40:1–19.
6.
Schwarz IM, King ET Jr. Bronchiolitis. In: Interstitial Lung Disease, 4th edition. 2003, pp. 787-817.
7.
Lazarus CS. Disorders of the Intrathoracic Airways. In: Mason J. Robert, V. Courtney Broaddus, John F. Murray, Jay A. Nadel (eds). Textbook of Respiratory Medicine, 4th edition, Philadelphia, Elsevier Saunders, 2005, pp 1295-304.
8.
Ryu HJ, Myers LJ, Swensen JS. Bronchiolar Disorders. State of the Art. Am J Respir Crit Care Med 2003;168:1277–92.
10.
Colby TV. Bronchiolitis: pathologic considerations. Am J Clin Pathol 1998;109:101–9.
11.
Poletti V, Casoni G, Zompatori M, Chilosi M. Bronchiolitis. Costabel U, du Bois RM, Egan JJ (eds): Diffuse Parenchymal Lung Disease. Prog Respir Res. Basel, Karger, 2007, vol 36, pp 292–306.
12.
Isabela C, Silva S, Müller LN. Bronchiolitis. In Nestor L. Müller, C. Isabela, S. Silva (eds), Imaging of the chest. Philadelphia, Elsevier Saunders, 2008, pp. 1071-95.
13.
Hansell DM. HRCT of obliterative bronchiolitis and other small airways disease. Semin Roentgenol 2001;36:51–65.
14.
Lucidarme O, Grenier PA, Cadi M, et al. Evaluation of air trapping at CT: comparison of continuous- versus suspended-expiration CT techniques. Radiology 2000;216:768-72.
15.
Markopoulo KD, Cool CD, Elliott TL, et al. Obliterative bronchiolitis: varying presentations and clinicopathological correlation. Eur Respir J 2002;19:20–30.
16.
Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositisdermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164:1182-85.
17.
Wells AU, du Bois RM. Bronchiolitis in association with connective tissue disorders. Clin Chest Med 1993;14:655–66.
18.
Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21(3): 297–310.
19.
Poletti V, Casoni G, Zompatori M, Carloni A, Chilosi M. Obliterative Bronchiolitis: Classification, Causes and Overview. In Interstitial Pulmonary and Bronchiolar Disorders. 2008. p. 525-42.
20.
Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002;166:440–4.
21.
Verleden MG, Dupont LJ, Vanaudenarede MB, Vos R, Van Raemdonck ME. Obliterative Bronchiolitis Following Lung or Heart-Lung Transplantation. In Interstitial Pulmonary and Bronchiolar Disorders 2008 pp. 543-57.
22.
Verleden GM, Fisher AJ, Boehler A, Estenne M. Bronchiolitis obliterans syndrome. In: Lung Transplantation. ERS Monographs 2009, pp 197-211.
23.
Yates B, Murphy DM, Forrest IA, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005;172(6):772–5.
24.
Brown MJ, English J, Muller NL. Bronchiolitis obliterans due to neuroendocrine hyperplasia: high-resolution CT–pathologic correlation. AJR Am J Roentgenol 1997;168:1561–2.
25.
Miller RR, Muller NL. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol 1995;19:653–8.
26.
Hasegawa Y, Shimokata K, Ichiyama S, et al. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J 1999;13:934–7.
27.
Colby TV, Camus P. Pathology of pulmonary involvement in inflammatory bowel disease. Eur Respir Mon 2007;39:199– 207.
28.
Wang JS, Tseng HH, Lai RS, Hsu HK, Ger LP. Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitis: histopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression. Histopathology 2000;37:402–10.
29.
Boehler A, Vogt P, Speich R, Weder W, Russi EW. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J 1996;9:1317–9.
30.
Nousari HC, Deterding R, Wojtczack H, et al. The mechanism of respiratory involvement in paraneoplastic pemphigus. N Engl J Med 1999;340:1406–10.
31.
Myers J, Colby T. Pathological manifestations of bronchiolitis, constrictive bronchiolitis, cryptogenic organizing pneumonia, and diffuse panbronchiolitis. Clin Chest Med 1993;14:611– 22.
32.
Fraser RS, Colman N, Müller NL, Paré PD. Disease of the airways. In Fraser RS, Colman N, Mόller NL, Parι PD (eds), Synopsis of Diseases of the Chest. Philadelphia, Elsevier Saunders, 2005, pp 627-713.
33.
Kraft M, Mortenson RL, Colby TV, Newman L, Waldron JA Jr, King TE Jr. Cryptogenic constrictive bronchiolitis: a clinicopathologic study. Am Rev Respir Dis 1993;148:1093–101.
34.
David A. Lynch, MD. Imaging of Small Airways Disease and Chronic Obstructive Pulmonary Disease. Clin Chest Med 2008;29:165–79.
35.
Visscher WD, Myers LJ. Bronchiolitis. The Pathologist’s Perspective. Proc Am Thorac Soc 2006;Vol 3:41–7.
36.
Andersen P. Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax 1998;53:302–7.
37.
Poletti V, Chilosi M, Zompatori M. Bronchiolitis; in Gibson GJ, Geddes DM, Costabel U, Sterk PJ, Corrin B (eds): Respiratory Medicine. Philadelphia, Saunders, 2003, vol 2, pp 1526–39.
38.
Carroll KN, Wu P, Gebretsadik T, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J Allergy Clin Immunol 2009;123:1055– 61.
39.
Mcnamara PS, Syth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002;61:13–28.
40.
Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917–28.
41.
Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. RadioGraphics 2002;22: S137-S149.
42.
King ET, Kinder WB. Bronchiolitis. In: Fishman’s Pulmonary Diseases and Disorders, Fourth Edition, 2008 pp. 887-911.
43.
Pipavath JS, Lynch AD, Cool C, Brown KK, Newell DJ. Radiologic and Pathologic Features of Bronchiolitis. AJR 2005;185:354– 63.
44.
Collins J, Blankenbaker D, Stern EJ. CT patterns of bronchiolar disease: what is “tree-in-bud? Am J Roentgenol 1998;171:365– 70.
45.
Marti-Bonmati L, Ruiz Perales F, Catala F, et al. CT findings in Swyer-James syndrome. Radiology 1989;172(2):477–80.
46.
Pipavath NJS, Stern JE. Imaging of Small Airway Disease (SAD) in Imaging of Airway Diseases, Radiologic Clinics of North America 2009;47:307–16.
47.
Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM, Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996;154:497–503.
48.
Nishimura K, Kitaichi M, Izumi T, et al. Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings. Radiology 1992;184(3):779–85.
49.
Oda H, Kadota J, Kohno S, Hara K. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Chest 1995;108:116–22.
50.
Pipavath SJ, Lynch DA, Cool C, Brown KK, Newell JD. Radiologic and pathologic features of bronchiolitis. Am J Roentgenol 2005;185:354–63.
51.
Sugiyama Y, Kudoh S, Maeda H, et al. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1990;141:1459–62.
52.
Keicho N, Kudoh S. Diffuse panbronchiolitis: role of macrolides in therapy. Am J Respir Med 2002;1:119-31.
53.
Elkin SL, Nicholson AG, du Bois RM. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Semin Respir Crit Care Med 2001;22:387–97.
54.
Fraig M, Shreesha U, Savici D, Katzenstein ALA. Respiratory bronchiolitis: a clinicopathlogic study in current smokers, ex smokers, and never-smokers. Am J Surg Pathol 2002;26:647–53.
55.
Hansell DM, Nicholson AG. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med 2003;24(4):377–92.
56.
Heyneman LE, Ward S, Lynch DA, Remy-Jardin M, Johkoh T, Müller NL. Respiratory bronchiolitis, respiratory bronchiolitisassociated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? Am J Roentgenol 1999;173:1617–22.
57.
Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998;157:1658–65.
58.
Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/ bronchiolitis. Hum Pathol 1985;16:700–6.
59.
Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JA, Muller NL. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999;212:637–42.
60.
Douglas WW, Norman G, Hepper G, et al. Silo-filler’s disease. Mayo Clin Proc 1989;64:291–304.
62.
Rigner KG, Swensson A. Late prognosis of nitrous fume poisoning and follow-up study. Acta Med Scand 1961;170:291–9.
63.
Churg A. Mineral dust induced bronchiolitis. In: Epler GR, editor. Diseases of the bronchioles. New York: Raven Press, Ltd.; 1994, p. 27–41.
64.
Churg A. Small airways disease associated with mineral dust exposure. Sem Respir Med 1992;13:140–5.
65.
Churg A, Wright JL, Wiggs B, et al. Small airways disease and mineral dust exposure. Am Rev Respir Dis 1985;131:139–43.
66.
Begin R, Boileau R, Peloquin S. Asbestos exposure, cigarette smoking, and airflow limitation in long-term Canadian chrysotile miners and millers. Am J Indust Med 1987;11:55–66.
67.
Wright JL, Tron V, Wiggs B, Churg A. Cigarette smoke potentiates asbestos-induced airflow abnormalities. Exp Lung Res 1988;14:537–48.
68.
Van de Laar MA, Westerman CJ, Wagenaar SS, Dinant HJ. Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans. Arthritis Rheum 1985;28:93–7.
69.
Cortot AB, Cottin V, Miossec P, et al. Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. Respir Med 2005;99:511–4.
70.
Gerbase MW, Spiliopoulos A, Fathi M, et al. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. Transplant Proceedings 2001;33:2146–7.
71.
Onsager DR, Canver CC, Jahania MS, et al. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant 1999;18:448–55.
72.
McNeil K, Glanville AR, Wahlers T, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation 2006;81:998–1003.
73.
Garrity ER, Villanueva J, Bhorade SM, et al. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation 2001;71:773–7.
74.
Verleden GM, Bankier A, Boehler A, et al. Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment. In: Verleden GM, Van Raemdonck D, Lerut T, Demedts M, eds. Surgery for Non-neoplastic Disorders of the Chest: a Clinical Update. Eur Respir Mon 2004;29:19–43.
75.
Johnson BA, Iacono AT, Zeevi A, McCurry KR, Duncan SR. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 2003;167:1271–78.
76.
Gottlieb J, Szangolies J, Koehnlein T, et al. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008;85:36–41.
77.
Strueber M, Fischer S, Gottlieb J, et al. Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg 2006;132:407–12.
78.
Friis B, Andersen P, Brene E, et al. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984;59:1038–45.
79.
Klassen TP, Rowe PC, Sutcliffe T, et al. Randomized trial of salbutamol in acute bronchiolitis. J Pediatr 1991;118:807–11.
80.
Caramia G, Palazzini E. Efficacy of ribavirin aerosol treatment for respiratory syncytial virus bronchiolitis in infants. J Int Med Res 1987;15:227–33.
81.
Plint AC, Johnson DW, Patel H, et al. Epinephrine and Dexamethasone in Children with Bronchiolitis. N Engl J Med 2009;360:2079-89.
82.
Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167:379-83.
83.
Wohl MEB, Chernick V. Bronchiolitis: state of the art. Am Rev Respir Dis 1978;118:759–81.
85.
Poletti V, Casoni G, Chilosi M, Zompatori M. Diffuse panbronchiolitis. Eur Respir J 2006;28: 862–71.
86.
Giamarellos-Bourboulis EJ. Macrolides beyond the conventional antimicrobials: a class of potent ommunomodulators. Int J Antimicrob Agents 2008;31(1):12-20.
87.
Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther 2008;117(3):393-405.
88.
Kudoh S. Erythromycin treatment in diffuse panbronchiolitis. Curr Opin Pulm Med 1998;4:116–21.
89.
Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis. 1992;145(3):548-52.
90.
Baz MA, Kussin PS, Trigt PV, et al. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med 1995;151:895–8.
91.
Romero S, Barroso E, Gil J, et al. Follicular bronchiolitis: clinical and pathologic findings in six patients. Lung 2003;181:309– 19.
92.
Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154:1531–6.
93.
Vassallo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care Med 2008;29(6):643-50.
94.
Horvath EP, Colico DGA, Barbee RA, Dickie HA. Nitrogen dioxideinduced pulmonary disease. J Occup Med 1978;20:103–10.
95.
do Nascimento TS, Pereira RO, de Mello HL, Costa J. Methemoglobinemia: from diagnosis to treatment. Rev Bras Anestesiol 2008;58(6):657-64.
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
